F. Gilbert McMahon

6.0k total citations · 1 hit paper
112 papers, 4.8k citations indexed

About

F. Gilbert McMahon is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Pharmacology. According to data from OpenAlex, F. Gilbert McMahon has authored 112 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pharmacology, 20 papers in Cardiology and Cardiovascular Medicine and 16 papers in Pharmacology. Recurrent topics in F. Gilbert McMahon's work include Blood Pressure and Hypertension Studies (15 papers), Pharmaceutical studies and practices (10 papers) and Pharmacogenetics and Drug Metabolism (9 papers). F. Gilbert McMahon is often cited by papers focused on Blood Pressure and Hypertension Studies (15 papers), Pharmaceutical studies and practices (10 papers) and Pharmacogenetics and Drug Metabolism (9 papers). F. Gilbert McMahon collaborates with scholars based in United States, Japan and Switzerland. F. Gilbert McMahon's co-authors include Ramón Vargas, Adesh K. Jain, Jerome R. Ryan, D E Duggan, K.C. Kwan, H. Donald Hochstein, Anthony S. Ridolfo, R Nickander, Anthony F. Suffredini and Everton Rowe and has published in prestigious journals such as The Lancet, JAMA and Annals of Internal Medicine.

In The Last Decade

F. Gilbert McMahon

106 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Pharmacological Basis of Therapeutics

1986 1.9k citations F. Gilbert McMahon profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. Gilbert McMahon United States	29	1.2k	775	641	641	603	112	4.8k
Eugene M. Sorkin United States	43	815 0.7×	895 1.2×	838 1.3×	814 1.3×	1.1k 1.8×	67	5.9k
Jan Olof Svensson Sweden	31	1.6k 1.3×	863 1.1×	680 1.1×	590 0.9×	864 1.4×	80	4.7k
D Pharm United States	4	903 0.7×	1.3k 1.7×	594 0.9×	685 1.1×	467 0.8×	5	6.2k
Donna McTavish New Zealand	45	793 0.7×	1.1k 1.4×	1.4k 2.1×	764 1.2×	585 1.0×	77	6.4k
Andrew Fitton United Kingdom	34	597 0.5×	758 1.0×	518 0.8×	399 0.6×	438 0.7×	53	4.1k
Rik C. Schoemaker Netherlands	45	1.1k 0.9×	950 1.2×	500 0.8×	468 0.7×	738 1.2×	198	6.2k
Alan Ward United States	19	915 0.8×	787 1.0×	473 0.7×	324 0.5×	391 0.6×	30	4.0k
Paul Benfield New Zealand	41	1.6k 1.3×	1.2k 1.6×	586 0.9×	523 0.8×	364 0.6×	84	6.6k
T.M. Speight New Zealand	59	1.5k 1.2×	1.6k 2.1×	980 1.5×	1.1k 1.7×	791 1.3×	109	8.5k
C. H. Gleiter Germany	18	822 0.7×	1.5k 1.9×	512 0.8×	588 0.9×	375 0.6×	46	6.3k

Countries citing papers authored by F. Gilbert McMahon

Since Specialization

Citations

This map shows the geographic impact of F. Gilbert McMahon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Gilbert McMahon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Gilbert McMahon more than expected).

Fields of papers citing papers by F. Gilbert McMahon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Gilbert McMahon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Gilbert McMahon. The network helps show where F. Gilbert McMahon may publish in the future.

Co-authorship network of co-authors of F. Gilbert McMahon

This figure shows the co-authorship network connecting the top 25 collaborators of F. Gilbert McMahon. A scholar is included among the top collaborators of F. Gilbert McMahon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Gilbert McMahon. F. Gilbert McMahon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lynn, Melvyn, Y. Nancy Wong, Richard Kao, et al.. (2004). Extended in Vivo Pharmacodynamic Activity of E5564 in Normal Volunteers with Experimental Endotoxemia. Journal of Pharmacology and Experimental Therapeutics. 308(1). 175–181. 32 indexed citations

Lynn, Melvyn, Daniel P. Rossignol, Richard Kao, et al.. (2003). Blocking of Responses to Endotoxin by E5564 in Healthy Volunteers with Experimental Endotoxemia. The Journal of Infectious Diseases. 187(4). 631–639. 127 indexed citations

McMahon, F. Gilbert, et al.. (2002). Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors. Journal of Human Hypertension. 16(1). 5–11. 73 indexed citations

Sramek, John J., Mark Leibowitz, Samuel Weinstein, et al.. (2002). Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by β-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial. Journal of Human Hypertension. 16(1). 13–19. 43 indexed citations

Suffredini, Anthony F., H. Donald Hochstein, & F. Gilbert McMahon. (1999). Dose‐Related Inflammatory Effects of Intravenous Endotoxin in Humans: Evaluation of a New Clinical Lot ofEscherichia coliO:113 Endotoxin. The Journal of Infectious Diseases. 179(5). 1278–1282. 130 indexed citations

Rubin, Bernard, F. Gilbert McMahon, David Lee, et al.. (1995). Comparison of the efficacy and safety of oxaprozin and nabumetone in the treatment of patients with osteoarthritis of the knee. Clinical Therapeutics. 17(4). 735–745. 24 indexed citations

Eisner, Gilbert M., Brian F. G. Johnson, F. Gilbert McMahon, et al.. (1991). A Multicenter Comparison of the Safety and Efficacy of Isradipine and Enalapril in the Treatment of Hypertension. American Journal of Hypertension. 4(2_Pt_2). 154S–157S. 10 indexed citations

Schnaper, Harold W., E. D. Freis, Wayne Hall, et al.. (1990). Potassium Restoration in Hypertensive Patients Made Hypokalemic by Hydrochlorothiazide. Survey of Anesthesiology. 34(5). 337–337. 1 indexed citations

McMahon, F. Gilbert, et al.. (1990). Some Problems With Antihypertensive Drug Studies in the Context of the New Guidelines. American Journal of Hypertension. 3(2). 151–155. 67 indexed citations

10.

McMahon, F. Gilbert, Andrew R. Johnson, & W. Colin Duncan. (1989). Some socioeconomic factors in the selection of blood pressure drugs in New Orleans, Louisiana. Cardiovascular Drugs and Therapy. 3(5). 753–755. 5 indexed citations

11.

McMahon, F. Gilbert, et al.. (1988). A double-blind study of ibuprofen 200 mg in combination with caffeine 100 mg, ibuprofen 400 mg, and placebo in episiotomy pain. Current Therapeutic Research. 43(4). 762–769. 14 indexed citations

12.

McMahon, F. Gilbert, et al.. (1988). An Acute Dose‐Response Pharmacodynamic Evaluation of Orally Administered Isradipine (PN‐200‐110) in Hypertensive Patients. The Journal of Clinical Pharmacology. 28(7). 664–666. 4 indexed citations

13.

Jain, Adesh K., et al.. (1988). A double-blind study of diflunisal and codeine compared with codeine or diflunisal alone in postoperative pain. Clinical Pharmacology & Therapeutics. 43(5). 529–535. 5 indexed citations

14.

Wilson, Michael F., Olga M. Haring, Andrew Lewin, et al.. (1986). Comparison of guanfacine versus clonidine for efficacy, safety and occurrence of withdrawal syndrome in step-2 treatment of mild to moderate essential hypertension. The American Journal of Cardiology. 57(9). E43–E49. 22 indexed citations

15.

Jain, Adesh K., et al.. (1986). Comparison of Oral Nalbuphine, Acetaminophen, and Their Combination in Postoperative Pain. Clinical Pharmacology & Therapeutics. 39(3). 295–299. 12 indexed citations

16.

McMahon, F. Gilbert. (1984). Management of essential hypertension : the new low-dose era. 26 indexed citations

17.

McMahon, F. Gilbert. (1980). Disulfiram-like reaction to a cephalospolin.. JAMA. 243. 2397.

18.

McMahon, F. Gilbert. (1975). Points from Letters: Potential Toxicity of Slow-K. BMJ. 3(5976). 162.6–162. 1 indexed citations

19.

McMahon, F. Gilbert, et al.. (1974). Evaluation of gastrointestinal, pulmonary, anti-inflammatory, and immunological agents. 1 indexed citations

20.

McMahon, F. Gilbert, et al.. (1974). Endocrine-Metabolic drugs.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact